Medicine & Life Sciences
fludarabine
100%
Cytarabine
75%
B-Cell Chronic Lymphocytic Leukemia
62%
triphosphoric acid
53%
Leukemia
46%
Nucleosides
44%
Arabinofuranosylcytosine Triphosphate
41%
gemcitabine
39%
2-fluoroadenine
36%
DNA
33%
Clofarabine
30%
Acute Myeloid Leukemia
28%
2-fluoro-araATP
24%
Pharmacokinetics
21%
fludarabine phosphate
18%
Vidarabine
18%
2'-cyano-2'-deoxyarabinofuranosylcytosine
17%
Apoptosis
16%
DNA Repair
15%
Nucleotides
14%
Therapeutics
13%
sapacitabine
12%
ara-ATP
12%
2'-deoxycytidine 5'-triphosphate
11%
Appointments and Schedules
11%
Deoxycytidine
11%
nelarabine
11%
Neoplasms
11%
Pharmacology
11%
DNA-Directed DNA Polymerase
10%
Hematologic Neoplasms
10%
Ribonucleotide Reductases
10%
Pharmaceutical Preparations
10%
7-hydroxystaurosporine
9%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9%
DNA Damage
8%
Deoxycytidine Kinase
7%
Lymphocytes
7%
Cell Death
7%
Clinical Studies
7%
Cell Line
7%
Purine Nucleosides
7%
Phosphorylation
6%
In Vitro Techniques
6%
PCI 32765
6%
2'-deoxyadenosine
6%
Cladribine
6%
venetoclax
6%
Survival
6%
Rituximab
6%
Chemistry
Triphosphate(5-)
10%
Nucleoside Analogue
9%
Gemcitabine
7%
Clofarabine
7%
Nucleotide
7%
Ribonucleotide
6%
Pharmacokinetics
6%
Pharmacological Metabolism
6%
Drug
6%
Dose
6%
Apoptotic
5%
Nucleoside
5%
Refractory
5%